"Like Indo-Australian relationship, nanobiotech has great potential"
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2014
Q: How do you look at the nano-biotech achievements in India so far? Have the applications been enough?Dr Pachauri: I th...Read more
Aus, Canada study find how diabetes drug metformin works
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2013
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...Read more
UBI doubled its revenue to $29.6 mn in FY 2012
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Singapore: Universal Biosensors reported its unaudited financial result for FY 2012 including a doubling of total revenu...Read more
Pfizer trial of cancer drug INLYTA is a failure
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2012
Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...Read more
ResMed builds on partnerships for growth
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2012
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...Read more
Agenix seeks China SFDA nod for hepatitis candidate
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013
Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial applic...Read more
Nanoparticles: A unique approach to cancer treatment
Australia | News | By Nandita Singh | 0 Comment | 14 Mar, 2012
Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...Read more
Prima cancer vaccine trial shows promise
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2012
Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...Read more
Starpharma reports financial results for FY 2011-12
Australia | Company results | By BioSpectrum Bureau | 4 Comment | 03 Sep, 2012
Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...Read more
GeneWorks develops DNA barcodes as security tool
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2012
Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...Read more
BioPharma Asia: Bionomics wins Innovative Asian Biotech of the Year Award
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2014
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...Read more
Mesoblast NeoFuse shows +ve results
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2013
Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...Read more
Australia approves drug for cystic fibrosis
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...Read more
Australian scientists discover new bowel cancer genes
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 May, 2012
Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...Read more
Algae.Tec hires biofuels expert
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Algae.Tec, an Australian biofuels company, has appointed Mr Colin McGregor as general manager project operati...Read more
EU patent for Phylomer ischemia peptides
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2013
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...Read more
Irish medtech firm Mainstay starts clinical trials
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Mar, 2014
Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being ...Read more
Investment bank expands life science team
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Oct, 2012
Singapore: International investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a ...Read more